Related content

p190 BCR-ABL rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22)

By Cividin M.   Brizard F.   Sorel N.   Renaud M.   Guilhot F.   Brizard A.  

Leukemia Research, Vol. 28, Iss. 1, 2004-01 ,pp. : 97-99

Elsevier

Access to resources Recommend Favorite

Not all imatinib resistance in CML are BCR-ABL kinase domain mutations

By Wei Yuan   Hardling Mats   Olsson Bob   Hezaveh Rahil   Ricksten Anne   Stockelberg Dick   Wadenvik Hans  

Annals of Hematology, Vol. 85, Iss. 12, 2006-12 ,pp. : 841-847

Springer Publishing Company

Access to resources Recommend Favorite

Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib

By Chahardouli Bahram   Zaker Farhad   Mousavi Seied Asadollah   Saffari Zeinab   Nadali Fatemeh   Ostadali Mohammadreza   Ghadimi Habibeh   Alimoghaddam Kamran   Ghavamzade Ardeshir   Rostami Shahrbano  

Hematology, Vol. 18, Iss. 6, 2013-11 ,pp. : 327-332

Maney Publishing

Access to resources Recommend Favorite

p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16)

By Dai Hai-ping  

International Journal of Hematology, Vol. 96, Iss. 6, 2012-12 ,pp. : 814-817

Springer Publishing Company

Access to resources Recommend Favorite

Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient

By Zámečníkova Adriana   Al Bahar Soad   Pandita Ramesh  

Hematology, Vol. 17, Iss. 6, 2012-11 ,pp. : 321-324

Maney Publishing

Access to resources Recommend Favorite